Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 217,273,813 papers from all fields of science
Search
Sign In
Create Free Account
Vitamin D3 Receptor
Known as:
Vitamin D 3 Receptors
, Receptors, 1,25-Dihydroxyvitamin D 3
, 1,25-Dihydroxyvitamin D3 Receptor
Expand
Proteins, usually found in the cytoplasm, that specifically bind calcitriol, migrate to the nucleus, and regulate transcription of specific segments…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
14 relations
CYP27B1 gene
Calcitriol
Cholecalciferol
Cholecalciferols
Expand
Narrower (1)
VDR protein, human
Broader (1)
vitamin receptor
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2018
Highly Cited
2018
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
R. Finn
,
S. Qin
,
+17 authors
A. Cheng
The Lancet
2018
Corpus ID: 46813550
Highly Cited
2005
Highly Cited
2005
Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up‐regulated in myeloid cells by 1,25‐dihydroxyvitamin D3
A. Gombart
,
N. Borregaard
,
H. Koeffler
The FASEB Journal
2005
Corpus ID: 7563259
The innate immune system of mammals provides a rapid response to repel assaults from numerous infectious agents including…
Expand
Highly Cited
2002
Highly Cited
2002
Vitamin D Receptor As an Intestinal Bile Acid Sensor
M. Makishima
,
T. T. Lu
,
+5 authors
D. Mangelsdorf
Science
2002
Corpus ID: 482537
The vitamin D receptor (VDR) mediates the effects of the calcemic hormone 1α,25-dihydroxyvitamin D3[1,25(OH)2D3]. We show that…
Expand
Review
2002
Review
2002
The mechanisms of action of PPARs.
J. Berger
,
D. Moller
Annual Review of Medicine
2002
Corpus ID: 11459441
The peroxisome proliferator-activated receptors (PPARs) are a group of three nuclear receptor isoforms, PPAR gamma, PPAR alpha…
Expand
Highly Cited
2001
Highly Cited
2001
Vitamin D3 promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of β-catenin signaling
H. G. Pálmer
,
J. González-Sancho
,
+8 authors
A. Muñoz
Journal of Cell Biology
2001
Corpus ID: 16569841
The β-catenin signaling pathway is deregulated in nearly all colon cancers. Nonhypercalcemic vitamin D3 (1α,25-dehydroxyvitamin…
Expand
Review
2000
Review
2000
The coregulator exchange in transcriptional functions of nuclear receptors.
C. Glass
,
M. Rosenfeld
Genes & Development
2000
Corpus ID: 12793980
Nuclear receptors (NR) comprise a family of transcription factors that regulate gene expression in a liganddependent manner…
Expand
Review
1999
Review
1999
Mechanism of action and in vivo role of platelet-derived growth factor.
C. Heldin
,
B. Westermark
Physiological Reviews
1999
Corpus ID: 26036265
Platelet-derived growth factor (PDGF) is a major mitogen for connective tissue cells and certain other cell types. It is a…
Expand
Review
1998
Review
1998
The Nuclear Vitamin D Receptor: Biological and Molecular Regulatory Properties Revealed
M. Haussler
,
G. Whitfield
,
+5 authors
P. Jurutka
Journal of Bone and Mineral Research
1998
Corpus ID: 18530628
IN THE DECADE SINCE THE VITAMIN D RECEPTOR (VDR) was cloned and recognized as a member of the superfamily of nuclear receptors…
Expand
Review
1994
Review
1994
GABAA receptor channels.
R. L. MacDonald
,
R. Olsen
Annual Review of Neuroscience
1994
Corpus ID: 8019215
This chapter discusses the gamma-aminobutyric acid (GABA) receptor channels, which are the most abundant inhibitory…
Expand
Highly Cited
1991
Highly Cited
1991
Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors
K. Umesono
,
K. Murakami
,
C. Thompson
,
R. Evans
Cell
1991
Corpus ID: 35801389
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE